| 今开：16.79 | 昨收：16.99 |
| 最高：16.96 | 最低：16.52 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.7466797E8 |
Core Laboratories(CLB)03-28 04:25
$Core Laboratories(CLB)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-037202 Act: 34 Size: 24 MB 网页链接查看全文
Core Laboratories(CLB)03-28 02:45
$Core Laboratories(CLB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-037061 Size: 16 KB 网页链接查看全文
Core Laboratories(CLB)04-03 05:15
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040329 Size: 8 KB 网页链接查看全文
Core Laboratories(CLB)今天 04:45
$Core Laboratories(CLB)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0000950170-24-047646 Act: 34 Size: 732 KB 网页链接查看全文
Core Laboratories(CLB)02-16 05:15
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-015883 Size: 6 KB 网页链接查看全文
Core Laboratories(CLB)03-19 18:05
$Core Laboratories(CLB)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-033021 Act: 34 Size: 17 MB 网页链接查看全文
Core Laboratories(CLB)03-19 18:05
$Core Laboratories(CLB)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-033023 Act: 34 Size: 84 KB 网页链接查看全文
Core Laboratories(CLB)03-26 04:45
$Core Laboratories(CLB)$ 8-K Current report, item 5.02 Accession Number: 0000950170-24-035962 Act: 34 Size: 188 KB 网页链接查看全文
Core Laboratories(CLB)04-03 05:05
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040323 Size: 8 KB 网页链接查看全文
Core Laboratories(CLB)02-14 06:05
$Core Laboratories(CLB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020682 Act: 34 Size: 13 KB 网页链接查看全文
格隆汇1月11日丨昨天涨逾4%的康龙化成(3759.HK)今日再涨4.8%，报115.8港元；公司A股逆势涨近2%，报130.9元。公司此前公布，收购Recipharm旗下原料药生产基地。里昂研报指，公司在核心实验室服务方面拥有丰富的经验，并正在扩展到后期CMC(化学、制造和控制)... 网页链接
同花顺（300033）金融研究中心8月6日讯，有投资者向华大基因（300676）提问， 公司目前除了深圳总部，还有哪些地区总部？是否均建设有p3实验室？？ 公司回答表示，您好，感谢您对华大基因的关注。公司总部位于中国深圳，在北京、天津... 网页链接
$Core Laboratories(CLB)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0000950170-24-047646 Act: 34 Size: 732 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-043822 Size: 5 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040329 Size: 8 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040339 Size: 8 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040347 Size: 10 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040354 Size: 8 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040316 Size: 8 KB 网页链接
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-040323 Size: 8 KB 网页链接
$Core Laboratories(CLB)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-037202 Act: 34 Size: 24 MB 网页链接
$Core Laboratories(CLB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-037061 Size: 16 KB 网页链接